Simple Summary Hepatocellular carcinoma (HCC) is a global health challenge. Hepatitis
virus infection (including HBV, HCV and HDV) is one of the major risk factors for HCC …

Chronic infection with hepatitis C virus (HCV) is a major cause of hepatocellular carcinoma
(HCC). Novel treatments with direct-acting antivirals achieve high rates of sustained …

Fibrosis is not a unidirectional, linear process, but a dynamic one resulting from an interplay
of fibrogenesis and fibrolysis depending on the extent and severity of a biologic insult, or …

Background Circular RNA (circRNA) is a key regulator for the malignant progression of
cancer. However, the role of circRNA anthrax toxin receptor 1 (circANTXR1) in …

Hepatocellular carcinoma (HCC) is a common and fatal cancer. People with HCC report
higher odds of comorbidity compared with people without HCC. To explore the association …

Hepatitis C virus (HCV) is a major cause of death and morbidity globally and is a leading
cause of hepatocellular carcinoma (HCC). Incidence of HCV infections, as well as HCV …

Hepatocellular carcinoma (HCC) is one of the most common malignancies with high
mortality and morbidity rates. In recent years, HCC targeted therapy has gained increasing …

Background Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third
leading cause of cancer deaths worldwide, seriously affecting human community health and …

Hepatitis C virus (HCV) is one of the major etiologies of hepatocellular carcinoma with
approximately 30% of HCC being due to HCV infection worldwide. HCV eradication by …

Idiopathic pulmonary fibrosis (IPF) is characterized by abnormal fibroblast accumulation in
the lung leading to extracellular matrix deposition and remodeling that compromise lung …